CFO Charl Keyter takes on Sibanye-Stillwater interim role

post-title

Charl Keyter, the chief financial officer at Sibanye-Stillwater, has been appointed as the interim chief commercial and development officer, effective immediately.

Charl Keyter, the chief financial officer at Sibanye-Stillwater, has been appointed as the interim chief commercial and development officer, effective immediately. He has taken over the new role following the resignation of Laurent Charbonnier. In addition to this interim role, Charl will continue his normal duties as CFO. 

Last year, Charl was nominated for the 2024 CFO Awards for his work as the CFO of Sibanye-Stillwater.  He joined the multinational mining and metals processing group  as a management accountant. In 2005 he was appointed acting senior manager of finance for the mine’s Venezuela operation. He was later promoted to group head of international finance and vice president in 2010 and became CFO in 2013. 

He has also previously served on the audit committee at Minerals Council South Africa. 

Charl holds a B.Com (Accounting) degree from the University of Johannesburg and a Masters in Business Administration from the North-West University. 

Related articles

iOCO’s Ashona Kooblall turns disciplined capital allocation into 39% profit growth

iOCO CFO Ashona Kooblall and CEO Rhys Summerton have lifted profit after tax by 39%, expanded return on equity to 35% and strengthened cash generation. With recurring revenue above 60% and a disciplined approach to acquisitions, debt reduction and share buybacks, Kooblall is focused on sustainable growth and long-term shareholder value.

The Retirement outcome every leader shapes

Retirement outcomes are built over decades, but the choices that shape them are often made by different people, in different institutions and at different points in an employee’s working life. New Old Mutual Corporate research gives CFOs a way to test whether the choices their organisations influence are turning employee-benefit spend into better retirement outcomes.

Top